Commercialization is typically the most capital-intensive phase for a medical device company. The product is technically de-risked after FDA clearance, but the business risk increases. The objective of the commercialization financial strategy is to secure sufficient capital to support manufacturing scale-up, sales organization development, and early adoption without facing a liquidity crisis during the slow initial revenue ramp.